Global Artemisinin and Derivatives Market Growth 2026-2032
The global Artemisinin and Derivatives market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Artemisinin is a sesquiterpene lactone compound derived from the sweet wormwood plant, scientifically known as Artemisia annua. It is a natural product with potent antimalarial properties, making it a key component in the treatment of malaria. Artemisinin and its derivatives are crucial compounds primarily used in the treatment of malaria, showcasing potent antimalarial properties. Common artemisinin derivatives include artemether, artesunate, and dihydroartemisinin.
United States market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Artemisinin and Derivatives players cover KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Artemisinin and Derivatives Industry Forecast? looks at past sales and reviews total world Artemisinin and Derivatives sales in 2025, providing a comprehensive analysis by region and market sector of projected Artemisinin and Derivatives sales for 2026 through 2032. With Artemisinin and Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin and Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin and Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin and Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artemisinin and Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin and Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin and Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Artemisinin is a sesquiterpene lactone compound derived from the sweet wormwood plant, scientifically known as Artemisia annua. It is a natural product with potent antimalarial properties, making it a key component in the treatment of malaria. Artemisinin and its derivatives are crucial compounds primarily used in the treatment of malaria, showcasing potent antimalarial properties. Common artemisinin derivatives include artemether, artesunate, and dihydroartemisinin.
United States market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Artemisinin and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Artemisinin and Derivatives players cover KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Artemisinin and Derivatives Industry Forecast? looks at past sales and reviews total world Artemisinin and Derivatives sales in 2025, providing a comprehensive analysis by region and market sector of projected Artemisinin and Derivatives sales for 2026 through 2032. With Artemisinin and Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin and Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin and Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin and Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artemisinin and Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin and Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin and Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Artemisinin
- Artemether
- Artesunate
- Dihydroartemisinin
- Antimalarial Drugs
- Antitumor and Anti-inflammatory Drugs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KPC Pharmaceuticals
- Guilin Nantang Pharmaceutical
- Chongqing Kerui Nanhai Pharmaceutical
- Sichuan Xieli Pharmaceutical
- Ipca Laboratories
- Aqre Group
- Cerata Pharmaceuticals
- What is the 10-year outlook for the global Artemisinin and Derivatives market?
- What factors are driving Artemisinin and Derivatives market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Artemisinin and Derivatives market opportunities vary by end market size?
- How does Artemisinin and Derivatives break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin and Derivatives Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Artemisinin and Derivatives by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Artemisinin and Derivatives by Country/Region, 2021, 2025 & 2032
2.2 Artemisinin and Derivatives Segment by Type
2.2.1 Artemisinin
2.2.2 Artemether
2.2.3 Artesunate
2.2.4 Dihydroartemisinin
2.2.5 Artemisinin and Derivatives Sales by Type
2.2.5.1 Global Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
2.2.5.2 Global Artemisinin and Derivatives Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Artemisinin and Derivatives Sale Price by Type (2021-2026)
2.3 Artemisinin and Derivatives Segment by Application
2.3.1 Antimalarial Drugs
2.3.2 Antitumor and Anti-inflammatory Drugs
2.3.3 Artemisinin and Derivatives Sales by Application
2.3.3.1 Global Artemisinin and Derivatives Sale Market Share by Application (2021-2026)
2.3.3.2 Global Artemisinin and Derivatives Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Artemisinin and Derivatives Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin and Derivatives Breakdown Data by Company
3.1.1 Global Artemisinin and Derivatives Annual Sales by Company (2021-2026)
3.1.2 Global Artemisinin and Derivatives Sales Market Share by Company (2021-2026)
3.2 Global Artemisinin and Derivatives Annual Revenue by Company (2021-2026)
3.2.1 Global Artemisinin and Derivatives Revenue by Company (2021-2026)
3.2.2 Global Artemisinin and Derivatives Revenue Market Share by Company (2021-2026)
3.3 Global Artemisinin and Derivatives Sale Price by Company
3.4 Key Manufacturers Artemisinin and Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin and Derivatives Product Location Distribution
3.4.2 Players Artemisinin and Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ AND DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin and Derivatives Market Size by Geographic Region (2021-2026)
4.1.1 Global Artemisinin and Derivatives Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Artemisinin and Derivatives Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Artemisinin and Derivatives Market Size by Country/Region (2021-2026)
4.2.1 Global Artemisinin and Derivatives Annual Sales by Country/Region (2021-2026)
4.2.2 Global Artemisinin and Derivatives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artemisinin and Derivatives Sales Growth
4.4 APAC Artemisinin and Derivatives Sales Growth
4.5 Europe Artemisinin and Derivatives Sales Growth
4.6 Middle East & Africa Artemisinin and Derivatives Sales Growth
5 AMERICAS
5.1 Americas Artemisinin and Derivatives Sales by Country
5.1.1 Americas Artemisinin and Derivatives Sales by Country (2021-2026)
5.1.2 Americas Artemisinin and Derivatives Revenue by Country (2021-2026)
5.2 Americas Artemisinin and Derivatives Sales by Type (2021-2026)
5.3 Americas Artemisinin and Derivatives Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin and Derivatives Sales by Region
6.1.1 APAC Artemisinin and Derivatives Sales by Region (2021-2026)
6.1.2 APAC Artemisinin and Derivatives Revenue by Region (2021-2026)
6.2 APAC Artemisinin and Derivatives Sales by Type (2021-2026)
6.3 APAC Artemisinin and Derivatives Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin and Derivatives by Country
7.1.1 Europe Artemisinin and Derivatives Sales by Country (2021-2026)
7.1.2 Europe Artemisinin and Derivatives Revenue by Country (2021-2026)
7.2 Europe Artemisinin and Derivatives Sales by Type (2021-2026)
7.3 Europe Artemisinin and Derivatives Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin and Derivatives by Country
8.1.1 Middle East & Africa Artemisinin and Derivatives Sales by Country (2021-2026)
8.1.2 Middle East & Africa Artemisinin and Derivatives Revenue by Country (2021-2026)
8.2 Middle East & Africa Artemisinin and Derivatives Sales by Type (2021-2026)
8.3 Middle East & Africa Artemisinin and Derivatives Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin and Derivatives
10.3 Manufacturing Process Analysis of Artemisinin and Derivatives
10.4 Industry Chain Structure of Artemisinin and Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin and Derivatives Distributors
11.3 Artemisinin and Derivatives Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ AND DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Artemisinin and Derivatives Market Size Forecast by Region
12.1.1 Global Artemisinin and Derivatives Forecast by Region (2027-2032)
12.1.2 Global Artemisinin and Derivatives Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Artemisinin and Derivatives Forecast by Type (2027-2032)
12.7 Global Artemisinin and Derivatives Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 KPC Pharmaceuticals
13.1.1 KPC Pharmaceuticals Company Information
13.1.2 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
13.1.3 KPC Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 KPC Pharmaceuticals Main Business Overview
13.1.5 KPC Pharmaceuticals Latest Developments
13.2 Guilin Nantang Pharmaceutical
13.2.1 Guilin Nantang Pharmaceutical Company Information
13.2.2 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Guilin Nantang Pharmaceutical Main Business Overview
13.2.5 Guilin Nantang Pharmaceutical Latest Developments
13.3 Chongqing Kerui Nanhai Pharmaceutical
13.3.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
13.3.2 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.3.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Kerui Nanhai Pharmaceutical Main Business Overview
13.3.5 Chongqing Kerui Nanhai Pharmaceutical Latest Developments
13.4 Sichuan Xieli Pharmaceutical
13.4.1 Sichuan Xieli Pharmaceutical Company Information
13.4.2 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.4.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Xieli Pharmaceutical Main Business Overview
13.4.5 Sichuan Xieli Pharmaceutical Latest Developments
13.5 Ipca Laboratories
13.5.1 Ipca Laboratories Company Information
13.5.2 Ipca Laboratories Artemisinin and Derivatives Product Portfolios and Specifications
13.5.3 Ipca Laboratories Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ipca Laboratories Main Business Overview
13.5.5 Ipca Laboratories Latest Developments
13.6 Aqre Group
13.6.1 Aqre Group Company Information
13.6.2 Aqre Group Artemisinin and Derivatives Product Portfolios and Specifications
13.6.3 Aqre Group Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aqre Group Main Business Overview
13.6.5 Aqre Group Latest Developments
13.7 Cerata Pharmaceuticals
13.7.1 Cerata Pharmaceuticals Company Information
13.7.2 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
13.7.3 Cerata Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cerata Pharmaceuticals Main Business Overview
13.7.5 Cerata Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin and Derivatives Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Artemisinin and Derivatives by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Artemisinin and Derivatives by Country/Region, 2021, 2025 & 2032
2.2 Artemisinin and Derivatives Segment by Type
2.2.1 Artemisinin
2.2.2 Artemether
2.2.3 Artesunate
2.2.4 Dihydroartemisinin
2.2.5 Artemisinin and Derivatives Sales by Type
2.2.5.1 Global Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
2.2.5.2 Global Artemisinin and Derivatives Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Artemisinin and Derivatives Sale Price by Type (2021-2026)
2.3 Artemisinin and Derivatives Segment by Application
2.3.1 Antimalarial Drugs
2.3.2 Antitumor and Anti-inflammatory Drugs
2.3.3 Artemisinin and Derivatives Sales by Application
2.3.3.1 Global Artemisinin and Derivatives Sale Market Share by Application (2021-2026)
2.3.3.2 Global Artemisinin and Derivatives Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Artemisinin and Derivatives Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin and Derivatives Breakdown Data by Company
3.1.1 Global Artemisinin and Derivatives Annual Sales by Company (2021-2026)
3.1.2 Global Artemisinin and Derivatives Sales Market Share by Company (2021-2026)
3.2 Global Artemisinin and Derivatives Annual Revenue by Company (2021-2026)
3.2.1 Global Artemisinin and Derivatives Revenue by Company (2021-2026)
3.2.2 Global Artemisinin and Derivatives Revenue Market Share by Company (2021-2026)
3.3 Global Artemisinin and Derivatives Sale Price by Company
3.4 Key Manufacturers Artemisinin and Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin and Derivatives Product Location Distribution
3.4.2 Players Artemisinin and Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ AND DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin and Derivatives Market Size by Geographic Region (2021-2026)
4.1.1 Global Artemisinin and Derivatives Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Artemisinin and Derivatives Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Artemisinin and Derivatives Market Size by Country/Region (2021-2026)
4.2.1 Global Artemisinin and Derivatives Annual Sales by Country/Region (2021-2026)
4.2.2 Global Artemisinin and Derivatives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artemisinin and Derivatives Sales Growth
4.4 APAC Artemisinin and Derivatives Sales Growth
4.5 Europe Artemisinin and Derivatives Sales Growth
4.6 Middle East & Africa Artemisinin and Derivatives Sales Growth
5 AMERICAS
5.1 Americas Artemisinin and Derivatives Sales by Country
5.1.1 Americas Artemisinin and Derivatives Sales by Country (2021-2026)
5.1.2 Americas Artemisinin and Derivatives Revenue by Country (2021-2026)
5.2 Americas Artemisinin and Derivatives Sales by Type (2021-2026)
5.3 Americas Artemisinin and Derivatives Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin and Derivatives Sales by Region
6.1.1 APAC Artemisinin and Derivatives Sales by Region (2021-2026)
6.1.2 APAC Artemisinin and Derivatives Revenue by Region (2021-2026)
6.2 APAC Artemisinin and Derivatives Sales by Type (2021-2026)
6.3 APAC Artemisinin and Derivatives Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin and Derivatives by Country
7.1.1 Europe Artemisinin and Derivatives Sales by Country (2021-2026)
7.1.2 Europe Artemisinin and Derivatives Revenue by Country (2021-2026)
7.2 Europe Artemisinin and Derivatives Sales by Type (2021-2026)
7.3 Europe Artemisinin and Derivatives Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin and Derivatives by Country
8.1.1 Middle East & Africa Artemisinin and Derivatives Sales by Country (2021-2026)
8.1.2 Middle East & Africa Artemisinin and Derivatives Revenue by Country (2021-2026)
8.2 Middle East & Africa Artemisinin and Derivatives Sales by Type (2021-2026)
8.3 Middle East & Africa Artemisinin and Derivatives Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin and Derivatives
10.3 Manufacturing Process Analysis of Artemisinin and Derivatives
10.4 Industry Chain Structure of Artemisinin and Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin and Derivatives Distributors
11.3 Artemisinin and Derivatives Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ AND DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Artemisinin and Derivatives Market Size Forecast by Region
12.1.1 Global Artemisinin and Derivatives Forecast by Region (2027-2032)
12.1.2 Global Artemisinin and Derivatives Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Artemisinin and Derivatives Forecast by Type (2027-2032)
12.7 Global Artemisinin and Derivatives Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 KPC Pharmaceuticals
13.1.1 KPC Pharmaceuticals Company Information
13.1.2 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
13.1.3 KPC Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 KPC Pharmaceuticals Main Business Overview
13.1.5 KPC Pharmaceuticals Latest Developments
13.2 Guilin Nantang Pharmaceutical
13.2.1 Guilin Nantang Pharmaceutical Company Information
13.2.2 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Guilin Nantang Pharmaceutical Main Business Overview
13.2.5 Guilin Nantang Pharmaceutical Latest Developments
13.3 Chongqing Kerui Nanhai Pharmaceutical
13.3.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
13.3.2 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.3.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Kerui Nanhai Pharmaceutical Main Business Overview
13.3.5 Chongqing Kerui Nanhai Pharmaceutical Latest Developments
13.4 Sichuan Xieli Pharmaceutical
13.4.1 Sichuan Xieli Pharmaceutical Company Information
13.4.2 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
13.4.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Xieli Pharmaceutical Main Business Overview
13.4.5 Sichuan Xieli Pharmaceutical Latest Developments
13.5 Ipca Laboratories
13.5.1 Ipca Laboratories Company Information
13.5.2 Ipca Laboratories Artemisinin and Derivatives Product Portfolios and Specifications
13.5.3 Ipca Laboratories Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ipca Laboratories Main Business Overview
13.5.5 Ipca Laboratories Latest Developments
13.6 Aqre Group
13.6.1 Aqre Group Company Information
13.6.2 Aqre Group Artemisinin and Derivatives Product Portfolios and Specifications
13.6.3 Aqre Group Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aqre Group Main Business Overview
13.6.5 Aqre Group Latest Developments
13.7 Cerata Pharmaceuticals
13.7.1 Cerata Pharmaceuticals Company Information
13.7.2 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
13.7.3 Cerata Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cerata Pharmaceuticals Main Business Overview
13.7.5 Cerata Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artemisinin and Derivatives Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Artemisinin and Derivatives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Artemisinin
Table 4. Major Players of Artemether
Table 5. Major Players of Artesunate
Table 6. Major Players of Dihydroartemisinin
Table 7. Global Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 8. Global Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Table 9. Global Artemisinin and Derivatives Revenue by Type (2021-2026) & ($ million)
Table 10. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2026)
Table 11. Global Artemisinin and Derivatives Sale Price by Type (2021-2026) & (US$/Kg)
Table 12. Global Artemisinin and Derivatives Sale by Application (2021-2026) & (Tons)
Table 13. Global Artemisinin and Derivatives Sale Market Share by Application (2021-2026)
Table 14. Global Artemisinin and Derivatives Revenue by Application (2021-2026) & ($ million)
Table 15. Global Artemisinin and Derivatives Revenue Market Share by Application (2021-2026)
Table 16. Global Artemisinin and Derivatives Sale Price by Application (2021-2026) & (US$/Kg)
Table 17. Global Artemisinin and Derivatives Sales by Company (2021-2026) & (Tons)
Table 18. Global Artemisinin and Derivatives Sales Market Share by Company (2021-2026)
Table 19. Global Artemisinin and Derivatives Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Artemisinin and Derivatives Revenue Market Share by Company (2021-2026)
Table 21. Global Artemisinin and Derivatives Sale Price by Company (2021-2026) & (US$/Kg)
Table 22. Key Manufacturers Artemisinin and Derivatives Producing Area Distribution and Sales Area
Table 23. Players Artemisinin and Derivatives Products Offered
Table 24. Artemisinin and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artemisinin and Derivatives Sales by Geographic Region (2021-2026) & (Tons)
Table 28. Global Artemisinin and Derivatives Sales Market Share Geographic Region (2021-2026)
Table 29. Global Artemisinin and Derivatives Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Artemisinin and Derivatives Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Artemisinin and Derivatives Sales by Country/Region (2021-2026) & (Tons)
Table 32. Global Artemisinin and Derivatives Sales Market Share by Country/Region (2021-2026)
Table 33. Global Artemisinin and Derivatives Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Artemisinin and Derivatives Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 36. Americas Artemisinin and Derivatives Sales Market Share by Country (2021-2026)
Table 37. Americas Artemisinin and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 39. Americas Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 40. APAC Artemisinin and Derivatives Sales by Region (2021-2026) & (Tons)
Table 41. APAC Artemisinin and Derivatives Sales Market Share by Region (2021-2026)
Table 42. APAC Artemisinin and Derivatives Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 44. APAC Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 45. Europe Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 46. Europe Artemisinin and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 48. Europe Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 49. Middle East & Africa Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 50. Middle East & Africa Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 52. Middle East & Africa Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 53. Key Market Drivers & Growth Opportunities of Artemisinin and Derivatives
Table 54. Key Market Challenges & Risks of Artemisinin and Derivatives
Table 55. Key Industry Trends of Artemisinin and Derivatives
Table 56. Artemisinin and Derivatives Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artemisinin and Derivatives Distributors List
Table 59. Artemisinin and Derivatives Customer List
Table 60. Global Artemisinin and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 61. Global Artemisinin and Derivatives Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 63. Americas Artemisinin and Derivatives Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Artemisinin and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 65. APAC Artemisinin and Derivatives Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Europe Artemisinin and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Middle East & Africa Artemisinin and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Artemisinin and Derivatives Sales Forecast by Type (2027-2032) & (Tons)
Table 71. Global Artemisinin and Derivatives Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Artemisinin and Derivatives Sales Forecast by Application (2027-2032) & (Tons)
Table 73. Global Artemisinin and Derivatives Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. KPC Pharmaceuticals Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 75. KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
Table 76. KPC Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 77. KPC Pharmaceuticals Main Business
Table 78. KPC Pharmaceuticals Latest Developments
Table 79. Guilin Nantang Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 80. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 81. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 82. Guilin Nantang Pharmaceutical Main Business
Table 83. Guilin Nantang Pharmaceutical Latest Developments
Table 84. Chongqing Kerui Nanhai Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 85. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 86. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 87. Chongqing Kerui Nanhai Pharmaceutical Main Business
Table 88. Chongqing Kerui Nanhai Pharmaceutical Latest Developments
Table 89. Sichuan Xieli Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 90. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 91. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. Sichuan Xieli Pharmaceutical Main Business
Table 93. Sichuan Xieli Pharmaceutical Latest Developments
Table 94. Ipca Laboratories Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 95. Ipca Laboratories Artemisinin and Derivatives Product Portfolios and Specifications
Table 96. Ipca Laboratories Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Ipca Laboratories Main Business
Table 98. Ipca Laboratories Latest Developments
Table 99. Aqre Group Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 100. Aqre Group Artemisinin and Derivatives Product Portfolios and Specifications
Table 101. Aqre Group Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Aqre Group Main Business
Table 103. Aqre Group Latest Developments
Table 104. Cerata Pharmaceuticals Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 105. Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
Table 106. Cerata Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Cerata Pharmaceuticals Main Business
Table 108. Cerata Pharmaceuticals Latest Developments
Table 1. Artemisinin and Derivatives Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Artemisinin and Derivatives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Artemisinin
Table 4. Major Players of Artemether
Table 5. Major Players of Artesunate
Table 6. Major Players of Dihydroartemisinin
Table 7. Global Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 8. Global Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Table 9. Global Artemisinin and Derivatives Revenue by Type (2021-2026) & ($ million)
Table 10. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2026)
Table 11. Global Artemisinin and Derivatives Sale Price by Type (2021-2026) & (US$/Kg)
Table 12. Global Artemisinin and Derivatives Sale by Application (2021-2026) & (Tons)
Table 13. Global Artemisinin and Derivatives Sale Market Share by Application (2021-2026)
Table 14. Global Artemisinin and Derivatives Revenue by Application (2021-2026) & ($ million)
Table 15. Global Artemisinin and Derivatives Revenue Market Share by Application (2021-2026)
Table 16. Global Artemisinin and Derivatives Sale Price by Application (2021-2026) & (US$/Kg)
Table 17. Global Artemisinin and Derivatives Sales by Company (2021-2026) & (Tons)
Table 18. Global Artemisinin and Derivatives Sales Market Share by Company (2021-2026)
Table 19. Global Artemisinin and Derivatives Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Artemisinin and Derivatives Revenue Market Share by Company (2021-2026)
Table 21. Global Artemisinin and Derivatives Sale Price by Company (2021-2026) & (US$/Kg)
Table 22. Key Manufacturers Artemisinin and Derivatives Producing Area Distribution and Sales Area
Table 23. Players Artemisinin and Derivatives Products Offered
Table 24. Artemisinin and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artemisinin and Derivatives Sales by Geographic Region (2021-2026) & (Tons)
Table 28. Global Artemisinin and Derivatives Sales Market Share Geographic Region (2021-2026)
Table 29. Global Artemisinin and Derivatives Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Artemisinin and Derivatives Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Artemisinin and Derivatives Sales by Country/Region (2021-2026) & (Tons)
Table 32. Global Artemisinin and Derivatives Sales Market Share by Country/Region (2021-2026)
Table 33. Global Artemisinin and Derivatives Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Artemisinin and Derivatives Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 36. Americas Artemisinin and Derivatives Sales Market Share by Country (2021-2026)
Table 37. Americas Artemisinin and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 39. Americas Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 40. APAC Artemisinin and Derivatives Sales by Region (2021-2026) & (Tons)
Table 41. APAC Artemisinin and Derivatives Sales Market Share by Region (2021-2026)
Table 42. APAC Artemisinin and Derivatives Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 44. APAC Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 45. Europe Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 46. Europe Artemisinin and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 48. Europe Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 49. Middle East & Africa Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons)
Table 50. Middle East & Africa Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons)
Table 52. Middle East & Africa Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons)
Table 53. Key Market Drivers & Growth Opportunities of Artemisinin and Derivatives
Table 54. Key Market Challenges & Risks of Artemisinin and Derivatives
Table 55. Key Industry Trends of Artemisinin and Derivatives
Table 56. Artemisinin and Derivatives Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artemisinin and Derivatives Distributors List
Table 59. Artemisinin and Derivatives Customer List
Table 60. Global Artemisinin and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 61. Global Artemisinin and Derivatives Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 63. Americas Artemisinin and Derivatives Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Artemisinin and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 65. APAC Artemisinin and Derivatives Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Europe Artemisinin and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Middle East & Africa Artemisinin and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Artemisinin and Derivatives Sales Forecast by Type (2027-2032) & (Tons)
Table 71. Global Artemisinin and Derivatives Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Artemisinin and Derivatives Sales Forecast by Application (2027-2032) & (Tons)
Table 73. Global Artemisinin and Derivatives Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. KPC Pharmaceuticals Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 75. KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
Table 76. KPC Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 77. KPC Pharmaceuticals Main Business
Table 78. KPC Pharmaceuticals Latest Developments
Table 79. Guilin Nantang Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 80. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 81. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 82. Guilin Nantang Pharmaceutical Main Business
Table 83. Guilin Nantang Pharmaceutical Latest Developments
Table 84. Chongqing Kerui Nanhai Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 85. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 86. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 87. Chongqing Kerui Nanhai Pharmaceutical Main Business
Table 88. Chongqing Kerui Nanhai Pharmaceutical Latest Developments
Table 89. Sichuan Xieli Pharmaceutical Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 90. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolios and Specifications
Table 91. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. Sichuan Xieli Pharmaceutical Main Business
Table 93. Sichuan Xieli Pharmaceutical Latest Developments
Table 94. Ipca Laboratories Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 95. Ipca Laboratories Artemisinin and Derivatives Product Portfolios and Specifications
Table 96. Ipca Laboratories Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Ipca Laboratories Main Business
Table 98. Ipca Laboratories Latest Developments
Table 99. Aqre Group Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 100. Aqre Group Artemisinin and Derivatives Product Portfolios and Specifications
Table 101. Aqre Group Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Aqre Group Main Business
Table 103. Aqre Group Latest Developments
Table 104. Cerata Pharmaceuticals Basic Information, Artemisinin and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 105. Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolios and Specifications
Table 106. Cerata Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Cerata Pharmaceuticals Main Business
Table 108. Cerata Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artemisinin and Derivatives
Figure 2. Artemisinin and Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin and Derivatives Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Artemisinin and Derivatives Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Artemisinin and Derivatives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Artemisinin and Derivatives Sales Market Share by Country/Region (2025)
Figure 10. Artemisinin and Derivatives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Artemisinin
Figure 12. Product Picture of Artemether
Figure 13. Product Picture of Artesunate
Figure 14. Product Picture of Dihydroartemisinin
Figure 15. Global Artemisinin and Derivatives Sales Market Share by Type in 2026
Figure 16. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2026)
Figure 17. Artemisinin and Derivatives Consumed in Antimalarial Drugs
Figure 18. Global Artemisinin and Derivatives Market: Antimalarial Drugs (2021-2026) & (Tons)
Figure 19. Artemisinin and Derivatives Consumed in Antitumor and Anti-inflammatory Drugs
Figure 20. Global Artemisinin and Derivatives Market: Antitumor and Anti-inflammatory Drugs (2021-2026) & (Tons)
Figure 21. Global Artemisinin and Derivatives Sale Market Share by Application (2025)
Figure 22. Global Artemisinin and Derivatives Revenue Market Share by Application in 2026
Figure 23. Artemisinin and Derivatives Sales by Company in 2026 (Tons)
Figure 24. Global Artemisinin and Derivatives Sales Market Share by Company in 2026
Figure 25. Artemisinin and Derivatives Revenue by Company in 2026 ($ millions)
Figure 26. Global Artemisinin and Derivatives Revenue Market Share by Company in 2026
Figure 27. Global Artemisinin and Derivatives Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Artemisinin and Derivatives Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 30. Americas Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 31. APAC Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 32. APAC Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 33. Europe Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 34. Europe Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 36. Middle East & Africa Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 37. Americas Artemisinin and Derivatives Sales Market Share by Country in 2026
Figure 38. Americas Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Figure 39. Americas Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 40. Americas Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 41. United States Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Artemisinin and Derivatives Sales Market Share by Region in 2026
Figure 46. APAC Artemisinin and Derivatives Revenue Market Share by Region (2021-2026)
Figure 47. APAC Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 48. APAC Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 49. China Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 53. India Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Artemisinin and Derivatives Sales Market Share by Country in 2026
Figure 57. Europe Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Figure 58. Europe Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 59. Europe Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 60. Germany Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 61. France Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 68. Egypt Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisinin and Derivatives in 2026
Figure 74. Manufacturing Process Analysis of Artemisinin and Derivatives
Figure 75. Industry Chain Structure of Artemisinin and Derivatives
Figure 76. Channels of Distribution
Figure 77. Global Artemisinin and Derivatives Sales Market Forecast by Region (2027-2032)
Figure 78. Global Artemisinin and Derivatives Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Artemisinin and Derivatives Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Artemisinin and Derivatives Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Artemisinin and Derivatives Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Artemisinin and Derivatives Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Artemisinin and Derivatives
Figure 2. Artemisinin and Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin and Derivatives Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Artemisinin and Derivatives Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Artemisinin and Derivatives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Artemisinin and Derivatives Sales Market Share by Country/Region (2025)
Figure 10. Artemisinin and Derivatives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Artemisinin
Figure 12. Product Picture of Artemether
Figure 13. Product Picture of Artesunate
Figure 14. Product Picture of Dihydroartemisinin
Figure 15. Global Artemisinin and Derivatives Sales Market Share by Type in 2026
Figure 16. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2026)
Figure 17. Artemisinin and Derivatives Consumed in Antimalarial Drugs
Figure 18. Global Artemisinin and Derivatives Market: Antimalarial Drugs (2021-2026) & (Tons)
Figure 19. Artemisinin and Derivatives Consumed in Antitumor and Anti-inflammatory Drugs
Figure 20. Global Artemisinin and Derivatives Market: Antitumor and Anti-inflammatory Drugs (2021-2026) & (Tons)
Figure 21. Global Artemisinin and Derivatives Sale Market Share by Application (2025)
Figure 22. Global Artemisinin and Derivatives Revenue Market Share by Application in 2026
Figure 23. Artemisinin and Derivatives Sales by Company in 2026 (Tons)
Figure 24. Global Artemisinin and Derivatives Sales Market Share by Company in 2026
Figure 25. Artemisinin and Derivatives Revenue by Company in 2026 ($ millions)
Figure 26. Global Artemisinin and Derivatives Revenue Market Share by Company in 2026
Figure 27. Global Artemisinin and Derivatives Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Artemisinin and Derivatives Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 30. Americas Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 31. APAC Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 32. APAC Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 33. Europe Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 34. Europe Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Artemisinin and Derivatives Sales 2021-2026 (Tons)
Figure 36. Middle East & Africa Artemisinin and Derivatives Revenue 2021-2026 ($ millions)
Figure 37. Americas Artemisinin and Derivatives Sales Market Share by Country in 2026
Figure 38. Americas Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Figure 39. Americas Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 40. Americas Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 41. United States Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Artemisinin and Derivatives Sales Market Share by Region in 2026
Figure 46. APAC Artemisinin and Derivatives Revenue Market Share by Region (2021-2026)
Figure 47. APAC Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 48. APAC Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 49. China Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 53. India Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Artemisinin and Derivatives Sales Market Share by Country in 2026
Figure 57. Europe Artemisinin and Derivatives Revenue Market Share by Country (2021-2026)
Figure 58. Europe Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 59. Europe Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 60. Germany Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 61. France Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Artemisinin and Derivatives Sales Market Share by Application (2021-2026)
Figure 68. Egypt Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Artemisinin and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisinin and Derivatives in 2026
Figure 74. Manufacturing Process Analysis of Artemisinin and Derivatives
Figure 75. Industry Chain Structure of Artemisinin and Derivatives
Figure 76. Channels of Distribution
Figure 77. Global Artemisinin and Derivatives Sales Market Forecast by Region (2027-2032)
Figure 78. Global Artemisinin and Derivatives Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Artemisinin and Derivatives Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Artemisinin and Derivatives Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Artemisinin and Derivatives Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Artemisinin and Derivatives Revenue Market Share Forecast by Application (2027-2032)
